Inhalation Anesthesia Market Share, Growth & Forecast [2031]

Segments - Inhalation Anesthesia Market by Applications (Induction, and Maintenance), Products (Sevoflurane, Isoflurane, and Desflurane), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Inhalation Anesthesia Market Outlook 2031

The Inhalation Anesthesia Market size was USD 1.46 Billion in 2022 and is likely to reach USD 3.18 Billion by 2031, expanding at a CAGR of 9.04% during 2023–2031. The growth of the market is attributed to the increasing geriatric population suffering from cardiovascular, orthopedic, neurological, respiratory, cancer, spinal, gastrointestinal, and other diseases and disorders.

Inhalational anesthesia (IA) come to be the anesthetic of choice over Intravenous Anesthesia (IVA) in many healthcare practitioners because it aids to avoid extreme dosage and keeps autonomic functions of patients intact. These drugs are eradicated through lugs and body have lower chance of retention. Inhaled routes of drugs have limited addiction and tolerance level as compared to other substitute routes.

Global Inhalation Anesthesia Market Outlook

IA is less costly than IVA and has a lower risk of dementia. Recently, number of surgical procedures are increasing which results growth in the inhalation anesthesia market. The rising number of orthopedic procedures include ligament repair and other soft tissue overhaul is propelling the daycare ambulatory surgeries growth which helps the market.

The anesthesia recycling market is anticipated to play important role in enhancing the market dynamics and competition. The anesthesia recycling market is growing significantly due to inhalation anesthetic’s environmental impact which is released from hospital environment into the atmosphere. Around 1% of global carbon dioxide is emitted from anesthetic gases which causes huge environmental damage.

While using anesthetic gases, the major concern is that patient uses only 5% and rest of it which is around 95% is released into the atmosphere that results in contribution to global warming. To deal the environmental effect of anesthetic gases, several new technologies are evolving for searching anesthetic gases from hospital vents and recycling them.

Anesthesia reclamation LLC, and Deltasorb Technologies (Blue Zone Technology) developed the anesthesia recycling systems. Anesthetic Recapture System was developed by Anesthesia reclamation LLC in which waste anesthetics from the operating rooms are collected by cryogenic condensing system.

Inhalation Anesthesia Market Trends, Drivers, Restraints, and Opportunities

Increasing prevalence of disorders such as respiratory diseases, gastrointestinal disorders, and cancer is major factor responsible for the market expansion during the forecast period.
Rising geriatric population, and growing number of surgical procedures across globe are projected to boost the market expansion.
Rising research and development in healthcare, and technological and scientific advancements are estimated to fuel the market growth.
Increasing demand of growing demand for a lesser duration of hospitalization, and growing accessibility to health services are expected to drive the growth of the market.
Inhalation anesthetics’ side effects is key factor that hinder the market expansion during the forecast period.
Lack of awareness among people and patent expiration are expected to hamper the market growth.

Scope of The Inhalation Anesthesia Market Report

The report on the global inhalation anesthesia market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Inhalation Anesthesia Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Applications (Induction, and Maintenance), Products (Sevoflurane, Isoflurane, and Desflurane)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Halocarbon Products Corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, and AbbVie Inc.

Inhalation Anesthesia Market Segment Insights

Induction segment is anticipated to expand at a rapid CAGR

On the basis of applications, the inhalation anesthesia market is segmented into induction and maintenance. The maintenance segment is expected to hold a key share of the market during the forecast period due to its huge requirement of volume for faster induction and maintenance along with recovery from anesthesia.

However, the induction segment is expected to grow at a lucrative CAGR over the forecast period during the forecast period. Induction of anesthesia needs greater concentration of drugs as compared to maintenance of anesthesia. There are some factors responsible for influencing induction of anesthesia such as Minimum Alveolar Concentration (MAC), patient’s age, compatibility with other drugs, potency, blood/gas solubility, therapeutic index of drug, and rate of metabolism by kidney/liver.

In central nervous system inhalation general anesthetic agents have mechanism of action that depends on blood and gas solubility and Minimum Alveolar Concentration (MAC) concentration of different drugs. Therefore, patients sensitive to anesthetic agents are supervised to evade recovery delays in anesthesia.

Global Inhalation Anesthesia Market Application

Sevoflurane segment is expected to hold a major share

Based on products, the inhalation anesthesia market is divided into sevoflurane, isoflurane, and desflurane. All these products are used in maintenance and induction of anesthesia during surgical products. Baxter Healthcare have all 3 products inside its portfolio and its only player. Piramal Healthcare and AbbVie Inc. have sevoflurane and isoflurane in their portfolio.

The sevoflurane segment is expected to account for a key share of the in the coming years due to its therapeutic advantages and low cost. Other two, desflurane and isoflurane are based on patient needs and the requirement for prolonged induction or maintenance of anesthesia. On the other hand, the isoflurane segment is anticipated to expand at a rapid pace during the forecast period due to sparing effect on cardiovascular function which makes it useful in the anesthetic management.

Global Inhalation Anesthesia Market Product

North America is expected to dominate the market

On the basis of regions, the inhalation anesthesia market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to rising prevalence of several chronic diseases and advanced healthcare facilities.

The demand of surgical products is increasing which includes ambulatory surgery and inpatient surgery. These surgeries are in high demand in North America which is anticipated to fuel the regional growth. However, the market of Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to incidence of chronic diseases and availability of healthcare insurance for masses.

Moreover, growing population, and public and private healthcare expenditure are projected to boost the regional growth. The increasing medical tourism along with rising penetration of insurance coverage are expected to aid more people to choose surgical products. Development of ambulatory healthcare centers is anticipated to propel the rise in population in Asia Pacific hence, positively impacting the market.

Global Inhalation Anesthesia Market Region

Segments

The global inhalation anesthesia market has been segmented on the basis of

Applications

Induction
Maintenance

Products

Sevoflurane
Isoflurane
Desflurane

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Halocarbon Products Corporation
Hikima Pharmaceuticals PLC
Lunan Pharmaceutical Group Co. Ltd.
Piramal Enterprises Limited
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius Kabi AG
AbbVie Inc.

Competitive Landscape

Key players competing in the inhalation anesthesia market include Halocarbon Products Corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, and AbbVie Inc. Key players are implementing several business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Global Inhalation Anesthesia Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Inhalation Anesthesia Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Inhalation Anesthesia Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Inhalation Anesthesia Market - Supply Chain
  4.5. Global Inhalation Anesthesia Market Forecast
     4.5.1. Inhalation Anesthesia Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Inhalation Anesthesia Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Inhalation Anesthesia Market Absolute $ Opportunity
5. Global Inhalation Anesthesia Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Inhalation Anesthesia Market Size and Volume Forecast by Types
     5.3.1. Sevoflurane
     5.3.2. Isoflurane
     5.3.3. Desflurane
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Inhalation Anesthesia Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Inhalation Anesthesia Market Size and Volume Forecast by Applications
     6.3.1. Induction
     6.3.2. Maintenance
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Inhalation Anesthesia Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Inhalation Anesthesia Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Inhalation Anesthesia Demand Share Forecast, 2019-2026
8. North America Inhalation Anesthesia Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Inhalation Anesthesia Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Inhalation Anesthesia Market Size and Volume Forecast by Types
     8.4.1. Sevoflurane
     8.4.2. Isoflurane
     8.4.3. Desflurane
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Inhalation Anesthesia Market Size and Volume Forecast by Applications
     8.7.1. Induction
     8.7.2. Maintenance
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Inhalation Anesthesia Demand Share Forecast, 2019-2026
9. Latin America Inhalation Anesthesia Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Inhalation Anesthesia Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Inhalation Anesthesia Market Size and Volume Forecast by Types
     9.4.1. Sevoflurane
     9.4.2. Isoflurane
     9.4.3. Desflurane
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Inhalation Anesthesia Market Size and Volume Forecast by Applications
     9.7.1. Induction
     9.7.2. Maintenance
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Inhalation Anesthesia Demand Share Forecast, 2019-2026
10. Europe Inhalation Anesthesia Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Inhalation Anesthesia Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Inhalation Anesthesia Market Size and Volume Forecast by Types
     10.4.1. Sevoflurane
     10.4.2. Isoflurane
     10.4.3. Desflurane
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Inhalation Anesthesia Market Size and Volume Forecast by Applications
     10.7.1. Induction
     10.7.2. Maintenance
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Inhalation Anesthesia Demand Share Forecast, 2019-2026
11. Asia Pacific Inhalation Anesthesia Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Inhalation Anesthesia Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Inhalation Anesthesia Market Size and Volume Forecast by Types
     11.4.1. Sevoflurane
     11.4.2. Isoflurane
     11.4.3. Desflurane
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Inhalation Anesthesia Market Size and Volume Forecast by Applications
     11.7.1. Induction
     11.7.2. Maintenance
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Inhalation Anesthesia Demand Share Forecast, 2019-2026
12. Middle East & Africa Inhalation Anesthesia Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Inhalation Anesthesia Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Inhalation Anesthesia Market Size and Volume Forecast by Types
     12.4.1. Sevoflurane
     12.4.2. Isoflurane
     12.4.3. Desflurane
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Inhalation Anesthesia Market Size and Volume Forecast by Applications
     12.7.1. Induction
     12.7.2. Maintenance
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Inhalation Anesthesia Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Inhalation Anesthesia Market: Market Share Analysis
  13.2. Inhalation Anesthesia Distributors and Customers
  13.3. Inhalation Anesthesia Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Halocarbon Products Corporation
     13.4.2. Hikima Pharmaceuticals PLC
     13.4.3. Lunan Pharmaceutical Group Co. Ltd.
     13.4.4. Piramal Enterprises Limited
     13.4.5. Jiangsu Hengrui Medicine Co. Ltd.
     13.4.6. Fresenius Kabi AG
     13.4.7. AbbVie Inc.